DNA double-strand break repair in blood development and lymphocyte diversification
DNA double-strand break repair in blood development and lymphocyte diversification
批准号:
MC_UU_00029/2
负责人:
Jonathan Chapman
金额:
$272.68万
依托单位:
依托单位国家:
英国
项目类别:
Intramural
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The repair of breaks in our DNA is vital for the survival of cells and prevention of cancer causingmutations. However, the white blood cells of our immune systems (lymphocytes) intentionally generate DNA breaks within certain genes at very specific points in their development, and use these as a means to generate intentional mutations that alter the types of antibodies and antigen defence molecules they produce. Achieving this is vital for our immune systems, as this ability to mutate and adapt these genes enables our cells to create defences that neutralise different threats, such as viruses, bacteria and even cancer cells. DNA repair is also important for the development of different blood cells, and it also supports the long-term production of blood as we age. We know this because people who inherit genetic faults that alter their ability to repair DNA breaks often lose their ability to generate blood, a disease referred to a bone marrow failure. Our recent research has uncovered several of the DNA repair mechanisms that are important for function of our immune systems. One goal of this programme is to investigate why distinct types of a related DNA repair mechanism are important for different aspects of lymphocyte development. We predict these differences can be explained by the different types of DNA damage they have evolved to repair. Some of the genes that encode the DNA repair machines involved in these processes are also mutated in inherited rare human bone marrow failure syndromes. We predict that both functions are linked to common processes. By defining these first in lymphocytes, we will also learn about how our bodies support the long-term production of blood, and also prevent blood cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the mechanism and specificity of the 53BP1-Rev7 non-homologous end joining pathway in immunity and oncogenesis
-
批准号:MR/R017549/1
-
项目类别:Research Grant
-
资助金额:$90.39万
-
财政年份:2018
-
负责人:Jonathan Chapman
-
依托单位:
A novel regulator of DNA double strand break repair fate with roles in immunity and oncogenesis
-
批准号:MR/M009971/1
-
项目类别:Research Grant
-
资助金额:$47.56万
-
财政年份:2015
-
负责人:Jonathan Chapman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Double Sine-Gordon方程长时间动力学问题的数值方法研究
-
批准号:2026JJ50109
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:宋怀玲
-
依托单位:
FAK-OTUD4-POLQ信号轴调控微同源介导末端连接修复(MMEJ)及肿瘤耐药的分子机制研究
-
批准号:32070713
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:袁健
-
依托单位:
长链非编码RNA调控DNA损伤修复参与乳腺癌化疗耐药的机制研究
-
批准号:31801144
-
项目类别:青年科学基金项目
-
资助金额:27.0万元
-
批准年份:2018
-
负责人:周博
-
依托单位:
染色体结构维持蛋白1在端粒DNA双链断裂损伤修复中的作用及其机理
-
批准号:31801145
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2018
-
负责人:毛苹苏
-
依托单位:
对角型Nichols代数及其Drinfeld double的结构和表示
-
批准号:11701019
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2017
-
负责人:陈佳蕾
-
依托单位:
SOSS和RPA参与同源重组修复的分子机制研究
-
批准号:31701181
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2017
-
负责人:陈红霞
-
依托单位:
miR-34a/MDM4/p53反馈通路在慢性淋巴细胞白血病细胞凋亡中的作用机制研究
-
批准号:81200360
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:范磊
-
依托单位:
李pseudo-双代数及其相关代数的构建研究
-
批准号:11226069
-
项目类别:数学天元基金项目
-
资助金额:3.0万元
-
批准年份:2012
-
负责人:孙钦秀
-
依托单位:
一个double B-box锌指蛋白基因OsBBX22b调控水稻光周期开花的机理研究
-
批准号:31201187
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:赵术珍
-
依托单位:
HPS (ep,pe和double)雄鼠生殖力低下的研究
-
批准号:31171446
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:冯力骏
-
依托单位: